News

AI losses and some new leadership hint at a possible stock market rotation. Cisco fell late. Cathie Wood and Nancy pick ...
Tempus AI’s TEM stock has surged nearly 13% since its second-quarter 2025 earnings release. The quarter saw strong top-line ...
Over the past two years, one of the most interesting healthcare companies to go public is none other than Tempus AI (NASDAQ: ...
The collaboration will fund early-stage clinical development of SB-4826, CIT’s first-in-class SUMO E1 inhibitor, for patients ...
Tempus AI raises 2025 revenue outlook again after strong Q2 growth in genomics and AI-driven oncology solutions.